Helsinki provides an ideal platform for genomic research, clinical trials and development of precision medicine.
Helsinki Biobank has collected tissue samples for 50 years and collection is continuous. Rich biobank data combined with extensive health records and register data offers a unique combination for medical research. Global pharma companies such as Biogen, Eisai, MSD and Pfizer have already partnered with Helsinki Biobank.